First Horizon Corp (FHN) · Oct 27, 2026 · Other events

First Horizon board adds Vanderbilt CEO; seat count rises to 13

Board expanded to 13 — 13 directors, up from 12

First Horizon’s board appointment adds Vanderbilt Medical Center CEO Jeffrey Balser and expands the board from 12 to 13 amid a balance-sheet reset.

First Horizon is navigating a balance-sheet reset: after its third-quarter 2026 results, the bank announced plans to sell roughly $4.5 billion of lower-yielding consumer mortgages to create flexibility for future loan growth. The filing adds a governance credential, not a new operating plan. Jeffrey Balser, CEO of Vanderbilt University Medical Center and dean of Vanderbilt University School of Medicine, joins both First Horizon’s and First Horizon Bank’s boards effective immediately. 〔0〕 His healthcare and Nashville institutional background could broaden the board’s local-market and healthcare expertise, but the filing gives no evidence of a change to strategy, risk appetite, or capital allocation.

The structural change is modest. The board amended its bylaws to increase the authorized board size from 12 to 13 members, with the new seat filled immediately by Balser. 〔1〕 The related-party disclosure is standard language and does not identify a new transaction or unusual exposure.

Bottom line: This is a credible but low-impact governance addition during a broader balance-sheet transition. It changes board composition, not the company’s near-term business trajectory.

Original filing on SEC EDGAR

More First Horizon Corp news

First Horizon board adds Vanderbilt CEO; seat count rises to 13 | FHN Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.